Citigroup Maintains Buy on HCA Healthcare, Lowers Price Target to $279
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Jason Cassorla maintains a Buy rating on HCA Healthcare (NYSE:HCA) but has lowered the price target from $324 to $279.
October 25, 2023 | 3:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Citigroup has maintained a Buy rating on HCA Healthcare but lowered the price target from $324 to $279.
The news is directly related to HCA Healthcare. While the Buy rating is maintained, the lowering of the price target might indicate a slower growth expectation, which could potentially impact the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100